Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new micardis clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on micardis
- Telmisartan Versus Ramipril After Acute Coronary Syndrome
Status: Recruiting, Condition Summary: Acute Coronary Syndrome; Myocardial Infarction; Coronary Disease - Filtered Trial for Telmisartan 40mg Non-Responder
Status: Recruiting, Condition Summary: Hypertension - Telmisartan/Amlodipine (80/10) Versus Telmisartan/Amlodipine (40/10) Versus amlodipine10 in Resistant Hypertension
Status: Recruiting, Condition Summary: Hypertension - Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
Status: Recruiting, Condition Summary: Hypertension - Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension
Status: Recruiting, Condition Summary: Hypertension - Open Label Study Telmisartan and Amlodipine in Hypertension
Status: Recruiting, Condition Summary: Hypertension - J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation
Status: Active, not recruiting, Condition Summary: Hypertension - An Open-Label, Long-Term Study of Telmisartan Plus Amlodipine Fixed-Dose Combination
Status: Recruiting, Condition Summary: Hypertension - Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
Status: Completed, Condition Summary: Hypertension; Dyslipidemias - Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities
Status: Completed, Condition Summary: Hypertension; Metabolic Syndrome X - Telmisartan80/HCTZ25 Versus telmisartan80/HCTZ12.5 in Hypertension Not Responding to telmisartan80/HCTZ12.5
Status: Completed, Condition Summary: Hypertension - A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. (ATHOS Study)
Status: Completed, Condition Summary: Hypertension - A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
Status: Recruiting, Condition Summary: Hypertension; Obesity - HALT Progression of Polycystic Kidney Disease (HALT PKD)
Status: Recruiting, Condition Summary: Kidney, Polycystic - PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Status: Completed, Condition Summary: Cerebrovascular Accident - Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients
Status: Recruiting, Condition Summary: Hypertension; Metabolic Syndrome; Hypertriglyceridemia - Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo
Status: Active, not recruiting, Condition Summary: Cardiovascular Diseases - 26-Week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
Status: Recruiting, Condition Summary: Hypertension - SMOOTH - Blood Pressure Control in Diabetic/Obese Patients
Status: Completed, Condition Summary: Hypertension; Diabetes Mellitus, Type 2 - PRISMA = Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
Status: Completed, Condition Summary: Hypertension - Combination of Telmisartan 80mg Plus Hydrochlothiazide 12.5mg to Telmisartan 80mg in Patients Failed in Telmisartan 80mg
Status: Completed, Condition Summary: Hypertension - Telmisartan80mg/hydrochlothiazide12.5mg (Micardis Plus) ABPM Study in China
Status: Completed, Condition Summary: Hypertension - The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-Diabetic, Normotensive Subjects
Status: Completed, Condition Summary: Obesity; Insulin Resistance - A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg [Micardis HCT] Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg [Diovan HCT] Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension.
Status: Completed, Condition Summary: Hypertension - Non-Responder Study to Telmisartan 40mg
Status: Completed, Condition Summary: Hypertension - PROBE Parallel 6-wk Treatment Comparing Telmisartan/HCT (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using ABPM
Status: Completed, Condition Summary: Hypertension - PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
Status: Completed, Condition Summary: Hypertension - A Randomized, Double-Blind, Placebo Controlled Comparison of Telmisartan HCT and Valsartan HCT in HTN Stage I/II Patient
Status: Completed, Condition Summary: Hypertension - 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
Status: Completed, Condition Summary: Hypertension - INNOVATION Study - Telmisartan (Micardis?) in Incipient Diabetic Nephropathy
Status: Completed, Condition Summary: Diabetic Nephropathies